US0028241000 - Common Stock
ABBOTT LABORATORIES
NYSE:ABT (4/24/2024, 7:04:00 PM)
Premarket: 106.77 -0.12 (-0.11%)106.89
-0.7 (-0.65%)
Abbott Laboratories engages in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. The company is headquartered in Abbott Park, Illinois and currently employs 115,000 full-time employees. The Company’s portfolio of technologies spans the spectrum of healthcare, with businesses and products in diagnostics, medical devices, nutritional and branded generic medicines. Its segments include Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment is engaged in the international sales of a broad line of branded generic pharmaceutical products. The Diagnostic Products segment is engaged in the worldwide sales of diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Nutritional Products segment is involved in the worldwide sales of a broad line of adult and pediatric nutritional products. The Medical Devices segment includes the worldwide sales of rhythm management, electrophysiology, heart failure, vascular, structural heart, neuromodulation, and diabetes care products.
ABBOTT LABORATORIES
100 Abbott Park Rd
ABBOTT PARK ILLINOIS 60064
P: 12246676100
CEO: Robert B. Ford
Employees: 115000
Website: https://www.abbott.com/
It's not just enough for a company to pay a dividend, investors should look for dividend growth stocks that can continue to pay.
These dividend stocks have proved time and again why they're the cream of the crop and will rise to the top once more.
The Nasdaq and S&P 500 tumbled below their 50-day lines.
ABT earnings call for the period ending March 31, 2024.
Here you can normally see the latest stock twits on ABT, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: